These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2028805)

  • 21. Comorbidity or consanguinity.
    Tyrer P
    Br J Psychiatry; 1996 Jun; 168(6):669-71. PubMed ID: 8773807
    [No Abstract]   [Full Text] [Related]  

  • 22. Adolescent physical abuse: risk for adolescent psychiatric disorders.
    Kaplan SJ; Pelcovitz D; Salzinger S; Weiner M; Mandel FS; Lesser ML; Labruna VE
    Am J Psychiatry; 1998 Jul; 155(7):954-9. PubMed ID: 9659863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS and multiple sclerosis: neural and mental features.
    Morriss R; Schaerf F; Brandt J; McArthur J; Folstein M
    Acta Psychiatr Scand; 1992 May; 85(5):331-6. PubMed ID: 1605052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychological comorbidity and length of stay in the general hospital.
    Saravay SM; Steinberg MD; Weinschel B; Pollack S; Alovis N
    Am J Psychiatry; 1991 Mar; 148(3):324-9. PubMed ID: 1992834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation and validation of the multiple sclerosis depression rating scale: a test specifically devised to investigate affective disorders in multiple sclerosis patients.
    Quaranta D; Marra C; Zinno M; Patanella AK; Messina MJ; Piccininni C; Batocchi AP; Gainotti G
    Clin Neuropsychol; 2012; 26(4):571-87. PubMed ID: 22428778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alexithymia and links with depression and anxiety in multiple sclerosis].
    Chahraoui K; Pinoit JM; Viegas N; Adnet J; Bonin B; Moreau T
    Rev Neurol (Paris); 2008 Mar; 164(3):242-5. PubMed ID: 18405774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive predictors of response to treatment for depression in multiple sclerosis.
    Julian LJ; Mohr DC
    J Neuropsychiatry Clin Neurosci; 2006; 18(3):356-63. PubMed ID: 16963585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of major depressive disorder and low self-esteem in medical inpatients.
    Silverstone PH; Lemay T; Elliott J; Hsu V; Starko R
    Can J Psychiatry; 1996 Mar; 41(2):67-74. PubMed ID: 8705965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychiatric lifetime diagnoses are associated with a reduced chance of seizure freedom after temporal lobe surgery.
    Koch-Stoecker SC; Bien CG; Schulz R; May TW
    Epilepsia; 2017 Jun; 58(6):983-993. PubMed ID: 28378900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of psychiatric disorders in Edmonton. Major depressive disorder.
    Spaner D; Bland RC; Newman SC
    Acta Psychiatr Scand Suppl; 1994; 376():7-15. PubMed ID: 8178688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients.
    Karadayi H; Arisoy O; Altunrende B; Boztas MH; Sercan M
    Int J Psychiatry Clin Pract; 2014 Jan; 18(1):45-51. PubMed ID: 24047424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuropsychiatry of multiple sclerosis.
    Mendez MF
    Int J Psychiatry Med; 1995; 25(2):123-30. PubMed ID: 7591490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychopathology and clinical features in an Italian sample of patients with myofascial and temporomandibular joint pain: preliminary data.
    Nifosì F; Violato E; Pavan C; Sifari L; Novello G; Guarda Nardini L; Manfredini D; Semenzin M; Pavan L; Marini M
    Int J Psychiatry Med; 2007; 37(3):283-300. PubMed ID: 18314857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of research diagnostic systems in an Edinburgh community sample.
    Dean C; Surtees PG; Sashidharan SP
    Br J Psychiatry; 1983 Mar; 142():247-56. PubMed ID: 6860877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and neurological disease. Their distinction and association.
    Caplan LR; Ahmed I
    Gen Hosp Psychiatry; 1992 May; 14(3):177-85. PubMed ID: 1318243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period].
    Fratalia L; Hernández B
    Neurologia; 2013 Sep; 28(7):443-4. PubMed ID: 22698595
    [No Abstract]   [Full Text] [Related]  

  • 37. Depressive episodes in patients with multiple sclerosis.
    Schiffer RB; Caine ED; Bamford KA; Levy S
    Am J Psychiatry; 1983 Nov; 140(11):1498-1500. PubMed ID: 6625001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients.
    Mattingly G; Baker K; Zorumski CF; Figiel GS
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):145-51. PubMed ID: 1627975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological assessment in patients with multiple sclerosis and mild functional impairment.
    Jennekens-Schinkel A; Lanser JB; van der Velde EA
    J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):757. PubMed ID: 1789860
    [No Abstract]   [Full Text] [Related]  

  • 40. Prior cognitive problems as the key to treating a patient with resistant depression.
    Frances A; Yudofsky SC
    Hosp Community Psychiatry; 1985 Jan; 36(1):11-2, 21. PubMed ID: 3967869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.